Skip to main content

Table 3 Factors with significant impact on 3-year survival rate in univariate analysis

From: The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer

Parameter

Non-survivors

Survivors

p-value

Positive LVSI

8 (66.7%)

92 (22.8%)

0.000

Adjuvant therapy

 No adjuvant therapy

6 (50%)

195 (48.8%)

0.012

 Brachytherapy

3 (25%)

126 (31.5%)

 

 Brachytherapy and EBRT

1 (8.3%)

71 (17.8%)

 

Recurrence

9 (75%)

44 (10.9%)

0.000

Recurrence time

9.22 ± 8.28

32.57 ± 17.94

0.000